113 related articles for article (PubMed ID: 11598446)
1. Imperative indications for conservative surgery for renal cell carcinoma: 20 years' experience.
Gacci M; Rizzo M; Lapini A; Serni S; Stefanucci S; Carini M
Urol Int; 2001; 67(3):203-8. PubMed ID: 11598446
[TBL] [Abstract][Full Text] [Related]
2. Nephron sparing surgery for central renal tumors: experience with 33 cases.
Black P; Filipas D; Fichtner J; Hohenfellner R; Thüroff JW
J Urol; 2000 Mar; 163(3):737-43. PubMed ID: 10687967
[TBL] [Abstract][Full Text] [Related]
3. [Surgical outcomes of nephron-sparing surgery for renal tumors].
Minowada S; Homma Y; Takeuchi T; Tomita K; Kameyama S; Ohta N; Kitamura T
Nihon Hinyokika Gakkai Zasshi; 2002 May; 93(4):555-61. PubMed ID: 12056040
[TBL] [Abstract][Full Text] [Related]
4. Parenchyma-conserving surgery for renal cell carcinoma.
Taari K; Salo JO; Rannikko S; Kärkkäinen P; Nordling S; Lehtonen T
Ann Chir Gynaecol Suppl; 1993; 206():54-8. PubMed ID: 8291871
[TBL] [Abstract][Full Text] [Related]
5. Management of small solitary unilateral renal cell carcinomas: impact of central versus peripheral tumor location.
Hafez KS; Novick AC; Butler BP
J Urol; 1998 Apr; 159(4):1156-60. PubMed ID: 9507821
[TBL] [Abstract][Full Text] [Related]
6. Clinical experience with nephron-sparing surgery in the presence of a normal contralateral kidney.
Steinbach F; Stöckle M; Hohenfellner R
Semin Urol Oncol; 1995 Nov; 13(4):288-91. PubMed ID: 8595553
[TBL] [Abstract][Full Text] [Related]
7. Disease outcome in patients with low stage renal cell carcinoma treated with nephron sparing or radical surgery.
Lerner SE; Hawkins CA; Blute ML; Grabner A; Wollan PC; Eickholt JT; Zincke H
J Urol; 1996 Jun; 155(6):1868-73. PubMed ID: 8618276
[TBL] [Abstract][Full Text] [Related]
8. Multiple ipsilateral renal tumors discovered at planned nephron sparing surgery: importance of tumor histology and risk of metachronous recurrence.
Blute M; Thibault GP; Leibovich BC; Cheville JC; Lohse CM; Zincke H
J Urol; 2003 Sep; 170(3):760-3. PubMed ID: 12913692
[TBL] [Abstract][Full Text] [Related]
9. Management and extended outcome of patients with synchronous bilateral solid renal neoplasms in the absence of von Hippel-Lindau disease.
Blute ML; Amling CL; Bryant SC; Zincke H
Mayo Clin Proc; 2000 Oct; 75(10):1020-6. PubMed ID: 11040850
[TBL] [Abstract][Full Text] [Related]
10. Nephron-sparing surgery for renal cell carcinoma in the solitary kidney.
Berdjis N; Hakenberg OW; Novotny V; Manseck A; Oehlschläger S; Wirth MP
Scand J Urol Nephrol; 2007; 41(1):10-3. PubMed ID: 17366096
[TBL] [Abstract][Full Text] [Related]
11. Prognostic factors influencing long-term survival of patients undergoing nephron-sparing surgery for nonmetastatic renal-cell carcinoma (RCC) with imperative indications.
Haferkamp A; Kurosch M; Pritsch M; Hatiboglu G; Macher-Goeppinger S; Pfitzenmaier J; Pahernik S; Wagener N; Hohenfellner M
Ann Surg Oncol; 2010 Feb; 17(2):544-51. PubMed ID: 19953334
[TBL] [Abstract][Full Text] [Related]
12. Imperative and elective indications for nephron-sparing surgery for renal tumors: long-term oncological follow-up.
Roos FC; Pahernik S; Brenner W; Thüroff JW
Aktuelle Urol; 2010 Jan; 41 Suppl 1():S70-6. PubMed ID: 20094960
[TBL] [Abstract][Full Text] [Related]
13. Contemporary management of renal cell carcinoma with coexistent renal artery disease: update of the Cleveland Clinic experience.
Hafez KS; Krishnamurthi V; Campbell SC; Novick AC
Urology; 2000 Sep; 56(3):382-6. PubMed ID: 10962299
[TBL] [Abstract][Full Text] [Related]
14. Outcome of nephron-sparing surgery: elective versus imperative indications.
Kural AR; Demirkesen O; Onal B; Obek C; Tunc B; Onder AU; Yalcin V; Solok V
Urol Int; 2003; 71(2):190-6. PubMed ID: 12890959
[TBL] [Abstract][Full Text] [Related]
15. The role of nephron sparing surgery for metastatic (pM1) renal cell carcinoma.
Krambeck AE; Leibovich BC; Lohse CM; Kwon ED; Zincke H; Blute ML
J Urol; 2006 Nov; 176(5):1990-5; discussion 1995. PubMed ID: 17070231
[TBL] [Abstract][Full Text] [Related]
16. [Nephron-sparing surgery for small renal cell carcinoma: clinical analysis of 21 cases].
Xiao YJ; Zheng SB; Tan WL; Chen T; Qi H; Shao ZQ; Jiang YD; Wu P; Zhang HJ
Di Yi Jun Yi Da Xue Xue Bao; 2005 Mar; 25(3):357-9. PubMed ID: 15772014
[TBL] [Abstract][Full Text] [Related]
17. Conservative surgery for renal cell carcinoma.
Terrone C; Favro M; Neira D; Rocca Rossetti S
Ann Urol (Paris); 1997; 31(3):137-44. PubMed ID: 9251830
[TBL] [Abstract][Full Text] [Related]
18. [Partial nephrectomy for renal cell carcinoma using a microwave tissue coagulator--postoperative recurrence and renal function].
Fujimoto K; Tanaka N; Hirao Y
Hinyokika Kiyo; 2005 Aug; 51(8):511-5. PubMed ID: 16164265
[TBL] [Abstract][Full Text] [Related]
19. [Long-term outcome of conservative surgery for kidney cancer: survival, blood pressure, and renal function].
Humke U; Siemer S; Uder M; Ziegler M
Ann Urol (Paris); 2002 Dec; 36(6):349-53. PubMed ID: 12611132
[TBL] [Abstract][Full Text] [Related]
20. Nephron-sparing surgery versus radical nephrectomy in the treatment of intracapsular renal cell carcinoma up to 7cm.
Antonelli A; Cozzoli A; Nicolai M; Zani D; Zanotelli T; Perucchini L; Cunico SC; Simeone C
Eur Urol; 2008 Apr; 53(4):803-9. PubMed ID: 18036730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
